Emergent BioSolutions Inc (EBS)
5.55
+0.28
(+5.31%)
USD |
NYSE |
May 17, 16:00
5.55
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Gross Profit (TTM): 460.50M for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 460.50M |
| December 31, 2023 | 317.60M |
| September 30, 2023 | 335.40M |
| June 30, 2023 | 323.50M |
| March 31, 2023 | 248.40M |
| December 31, 2022 | 385.50M |
| September 30, 2022 | 712.90M |
| June 30, 2022 | 732.20M |
| March 31, 2022 | 810.90M |
| December 31, 2021 | 891.30M |
| September 30, 2021 | 841.90M |
| June 30, 2021 | 957.60M |
| March 31, 2021 | 1.055B |
| December 31, 2020 | 925.20M |
| September 30, 2020 | 748.00M |
| June 30, 2020 | 705.90M |
| March 31, 2020 | 566.00M |
| December 31, 2019 | 550.10M |
| September 30, 2019 | 477.50M |
| June 30, 2019 | 395.40M |
| March 31, 2019 | 412.40M |
| December 31, 2018 | 382.90M |
| September 30, 2018 | 367.67M |
| June 30, 2018 | 370.28M |
| March 31, 2018 | 297.02M |
| Date | Value |
|---|---|
| December 31, 2017 | 302.70M |
| September 30, 2017 | 258.01M |
| June 30, 2017 | 241.16M |
| March 31, 2017 | 225.03M |
| December 31, 2016 | 219.10M |
| September 30, 2016 | 248.74M |
| June 30, 2016 | 270.50M |
| March 31, 2016 | 305.10M |
| December 31, 2015 | 269.54M |
| September 30, 2015 | 245.93M |
| June 30, 2015 | 213.78M |
| March 31, 2015 | 203.12M |
| December 31, 2014 | 210.83M |
| September 30, 2014 | 200.16M |
| June 30, 2014 | 194.93M |
| March 31, 2014 | 190.63M |
| December 31, 2013 | 195.80M |
| September 30, 2013 | 188.75M |
| June 30, 2013 | 176.29M |
| March 31, 2013 | 167.62M |
| December 31, 2012 | 169.80M |
| September 30, 2012 | 133.25M |
| June 30, 2012 | 137.52M |
| March 31, 2012 | 169.62M |
| December 31, 2011 | 160.24M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
248.40M
Minimum
Mar 2023
1.055B
Maximum
Mar 2021
622.02M
Average
635.95M
Median
Gross Profit (TTM) Benchmarks
| Avid Bioservices Inc | 10.21M |
| Viking Therapeutics Inc | -- |
| FibroGen Inc | 126.38M |
| Avinger Inc | 2.003M |
| RAPT Therapeutics Inc | -- |